Jin Medical International Ltd. (ZJYL)

NASDAQ: ZJYL · Real-Time Price · USD

2.300

+0.020 (0.88%)

At close: Apr 28, 2026, 4:00 PM EDT

2.250

-0.050 (-2.17%)

After-hours: Apr 28, 2026, 7:29 PM EDT

Jin Medical International Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Cash & Equivalents	7.46	8.14	6.93	4.79	3.67
Short-Term Investments	22.17	18.62	9.77	2.28	2.05
Cash & Short-Term Investments	29.63	26.76	16.7	7.07	5.73
Cash Growth	10.74%	60.24%	136.23%	23.43%	101.69%
Accounts Receivable	5.91	8.46	4.23	4.08	4.86
Other Receivables	-	0.1	4.24	0.04	0.41
Total Trade Receivables	5.91	8.56	8.47	4.12	5.27
Inventory	4.92	5.17	5.05	6.72	6.89
Other Current Assets	3.68	2.33	0.89	0.99	1.53
Total Current Assets	44.14	42.82	31.12	18.9	19.42
Net Property, Plant & Equipment	7.98	1.72	1.48	1.63	2.11
Other Intangible Assets	1.1	1.15	0.15	0.16	0.19
Other Long-Term Assets	0.14	0.12	0.15	0.25	0.18
Total Assets	53.37	45.8	32.9	20.94	21.9
Accounts Payable	3.26	3.01	3.39	4.11	5.35
Accrued Expenses	0.67	0.43	0.32	0.39	0.72
Short-Term Debt	18.84	11.32	4.11	-	-
Current Portion of Leases	0.07	0.19	-	-	-
Unearned Revenue	0.61	0.8	0.83	0.83	1.68
Other Current Liabilities	0.34	1.4	0.27	0.37	0.12
Total Current Liabilities	23.8	17.15	8.92	5.7	7.87
Long-Term Leases	-	0.1	-	-	-
Total Long-Term Liabilities	-	0.1	-	-	-
Total Liabilities	23.8	17.25	8.92	5.7	7.87
Common Stock	0.01	0.01	0.01	0.01	0.01
Additional Paid-in Capital	6.75	6.75	6.44	0.08	0.08
Accumulated Other Comprehensive Income	-0.92	-0.56	-1.4	-0.91	0.59
Retained Earnings	23.81	22.61	18.94	16.06	13.35
Total Common Shareholders' Equity	29.64	28.82	23.98	15.24	14.03
Minority Interest	-0.07	-0.26	-	-	-
Shareholders' Equity	29.57	28.55	23.98	15.24	14.03
Total Liabilities & Equity	53.37	45.8	32.9	20.94	21.9
Total Debt	18.91	11.6	4.11	0	0
Net Cash (Debt)	10.72	15.15	12.59	7.07	5.73
Net Cash Growth	-29.26%	20.41%	78.04%	23.43%	2879.90%
Net Cash Per Share	1.37	1.94	1.73	1.05	0.85
Book Value	29.64	28.82	23.98	15.24	14.03
Book Value Per Share	3.79	3.68	3.30	2.26	2.08
Tangible Book Value	28.54	27.67	23.82	15.07	13.84
Tangible Book Value Per Share	3.65	3.54	3.28	2.23	2.05

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q